ArticleBiochemical and biophysical research communications2010

Engineered drug-resistant immunocompetent cells enhance tumor cell killing during a chemotherapy challenge.

Anindya Dasgupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.